Similarly, previous literature also reported that TRIP-Br-1 was overexpressed in nasopharyngeal cancer, cervical cancer, and melanoma and regulated by a chemotherapeutic drug and its synthesized decoy peptide.48 Here, CXCL11 is linked to melanoma.